⚡ Quick Answer
What is the NEC baby formula lawsuit? As of August 2026, parents of premature infants are suing Mead Johnson (Enfamil) and Abbott Laboratories (Similac), alleging these manufacturers knew cow's milk-based formulas significantly increased the risk of necrotizing enterocolitis (NEC) in preterm infants but failed to warn hospitals and parents. NEC is a severe gastrointestinal disease that can cause bowel perforation, sepsis, lifelong disability, and death. Roughly 780 cases are active in a federal MDL, and state court juries have returned verdicts totaling over $625 million to date. No global settlement has been reached, but for the first time, a federal bellwether trial against Mead Johnson is proceeding to a jury rather than ending in summary judgment.
⚖️ Legally reviewed by William Ettenger, Esq.
Who Qualifies for an NEC Baby Formula Lawsuit
Eligibility focuses on premature or very low birth weight infants who developed NEC after receiving Enfamil or Similac — in the NICU, at home, or both. Parents and legal guardians may file on behalf of their child, including in cases of wrongful death.
Qualifying Criteria:
How Formula Manufacturers Caused Harm
Lawsuits allege that Mead Johnson and Abbott Laboratories knew — or should have known — that cow's milk-based formula dramatically increased the risk of NEC in premature infants, yet failed to adequately warn hospitals and parents. Four core patterns of alleged misconduct appear across active cases:
1. Failure to Warn About NEC Risk in Preterm Infants
Peer-reviewed research has long linked cow's milk-based formula to elevated NEC rates in premature infants compared to human milk. Lawsuits allege manufacturers had access to this science and failed to include adequate warnings on product labels and in materials provided to NICUs and caregivers.
2. Marketing Cow's Milk Formula for Vulnerable Preterm Infants
Enfamil and Similac were heavily marketed for use in NICUs — including for the most vulnerable, extremely premature infants — without clear guidance about the significantly elevated NEC risk that cow's milk proteins pose to developing preterm digestive systems.
3. Inadequate Guidance to Hospitals and Caregivers
Lawsuits allege manufacturers failed to provide sufficient clinical guidance to NICU staff about when cow's milk formula should be avoided or used with caution in preterm infants. The American Academy of Pediatrics has long recommended prioritizing human milk for premature infants — guidance manufacturers allegedly did not reinforce.
4. Prioritizing Market Share Over Infant Safety
Complaints allege both Mead Johnson and Abbott Laboratories prioritized NICU market penetration and commercial relationships over the safety of the most vulnerable neonatal patients — premature infants whose digestive systems are not equipped to safely process cow's milk proteins.
NEC Injuries & Complications Recognized in Active Claims
The strongest cases involve serious, documented NEC complications directly tied to formula use in the NICU. Courts consider both economic and non-economic damages when evaluating claims.
NEC Lawsuit Settlement Factors & Ranges
No global settlement has been reached in the federal MDL. State court juries have returned verdicts totaling over $625 million — including a $495 million verdict against Abbott (Missouri, July 2024), a $60 million verdict against Mead Johnson (Illinois, March 2024), and a $70 million verdict against Abbott (Cook County, April 2026). When individual cases resolve, compensation depends on several key factors:
- 🔴
Medical severity — bowel surgery, ostomy, perforation, sepsis, or permanent disability typically yield higher compensation
- 🔴
NICU length of stay — prolonged hospitalization and intensive care costs significantly increase claim value
- 📋
Documentation strength — NICU records, feeding logs, operative reports, pathology, and imaging are essential to claim strength
- 📅
Long-term outcomes — short bowel syndrome, neurological damage, or growth failure significantly strengthen claims
- ⚖️
Venue and jury trends — state courts in Missouri, Illinois, and California have produced major plaintiff verdicts; Abbott's federal bellwethers have ended in summary judgment four times, while Mead Johnson's own summary judgment motion was denied in May 2026
- 💀
Wrongful death — cases involving infant death carry the highest potential values, ranging from $1M to $5M+ depending on jurisdiction
$70 million — Abbott Laboratories (Similac Special Care 24), Cook County, Illinois, April 2026 — $53M compensatory + $17M punitive; four families; Abbott appealing
$495 million — Abbott Laboratories (Similac), Missouri state court, July 2024 — $95M compensatory + $400M punitive
$60 million — Mead Johnson (Enfamil), Illinois state court, March 2024
Defense verdict — Joint Abbott/Mead Johnson trial, Missouri state court, October 2024 — overturned; retrial ordered
Federal MDL Bellwether Track: Abbott has won summary judgment in four consecutive federal bellwether trials. Mead Johnson's summary judgment motion was denied in May 2026 (Inman v. Mead Johnson) — that case is now expected to reach a jury in August 2026, the first federal bellwether verdict this MDL will produce.
Illustrative Individual Settlement Ranges:
NEC with conservative care: $50,000 – $250,000+
NEC with surgery: $250,000 – $1M+
Long-term disability: $500,000 – $2M+
Wrongful death: $1M – $5M+
Disclaimer: No global settlement has been reached in the federal MDL. Ranges are based on litigation patterns and verdict reports and are educational only — not a guarantee of outcome. Actual results depend on case-specific facts, venue, and litigation developments.
Deadlines for Filing an NEC Lawsuit (State-by-State)
Each state has strict statutes of limitations for product liability and personal injury claims — typically 2 to 3 years. For claims involving minors, many states toll (pause) the deadline until the child turns 18, then add additional years. Missing your deadline permanently bars your claim.
| State | Standard SOL | Minor Tolling | Notes |
|---|---|---|---|
| Illinois | 2 years | Yes | $60M plaintiff verdict (March 2024); $70M Cook County verdict against Abbott (April 2026) — Abbott appealing; Illinois First District Appellate Court ruled Cook County is only proper venue for Illinois-resident cases — non-IL cases shifting to Madison County and other jurisdictions |
| Missouri | 5 years | Yes | $495M verdict against Abbott (July 2024); October 2024 defense verdict overturned by judge for defense misconduct — retrial ordered; strong plaintiff venue with longest SOL |
| California | 2 years | Yes | Active state court filings increasing in 2025–2026; 7th Circuit skeptical of keeping some claims in federal court (March 2026), which may further accelerate state filings |
| New York | 3 years | Yes | Longer standard SOL; individual state filings active |
| Texas | 2 years | Yes | Wrongful death claims must be filed within 2 years of the infant's death |
| Florida | 2 years | Yes | SOL recently shortened; consult an attorney immediately if your child's diagnosis occurred years ago |
| Louisiana | 1 year | Yes | Shortest SOL in the nation — act immediately |
| All Other States | Typically 2–3 years | Varies | Many states extend deadlines for minors. Do not assume it is too late — consult an attorney immediately to confirm your deadline. |
Discovery rules and minor tolling provisions can significantly extend filing windows. Do not assume it is too late without speaking to an attorney.
NEC Baby Formula Lawsuit Updates — 2026
Last updated August 2026. We update this section regularly with new case filings, MDL developments, and notable rulings.
Show earlier updates (2021–March 2026)
Find Out If Your Family Qualifies — Free Case Review
Attorneys are reviewing NEC baby formula cases nationwide — including state court filings in Missouri, Illinois, and California. You pay nothing unless compensation is recovered.
Start My Free Case ReviewHow the NEC Baby Formula Lawsuit Process Works
Attorneys accept NEC baby formula cases on contingency — you pay nothing unless compensation is recovered.
- Free confidential consultation — Share your child's NICU history, formula use, and NEC diagnosis with an attorney at no cost. No records are required before reaching out.
- Case review and evidence gathering — Your attorney reviews NICU records, feeding logs, operative reports, pathology, and all evidence of harm. Your attorney can assist in obtaining records you don't yet have.
- Identifying the products — Your attorney confirms which formula products were used and whether those products are subject to active litigation in state court or federal MDL proceedings.
- Determining the legal pathway — Given Abbott's four consecutive federal summary judgment wins, and Mead Johnson's own case now proceeding to trial for the first time, your attorney will evaluate whether state court (Missouri, Illinois, California) or the federal MDL is the stronger venue for your specific case. Claims are typically brought under product liability (failure to warn, defective design) and negligence theories.
- Filing the lawsuit — Your attorney files suit in the appropriate court. State court filings in plaintiff-friendly jurisdictions are increasing; the federal MDL continues to coordinate hundreds of additional cases.
- Discovery — Both sides exchange evidence: manufacturer internal documents, formula testing records, communications about known NEC risks, and marketing materials directed at NICUs and hospitals.
- Expert testimony — Neonatologists, gastroenterologists, pathologists, and formula design experts testify about NEC causation and the adequacy of manufacturer warnings. Expert qualification is particularly important given federal Daubert challenges that have dismissed four Abbott bellwether cases.
- Settlement or trial — Cases may settle through negotiation or proceed to trial. State court juries have awarded $625M+ to date, and the first federal bellwether verdict is expected from the Mead Johnson trial in August 2026. Attorneys continue to pursue the best possible outcome for each family.
Frequently Asked Questions
What is NEC and why are families filing lawsuits?
Necrotizing enterocolitis (NEC) is a life-threatening gastrointestinal disease most common in premature infants. It can cause bowel tissue to die, leading to perforation, sepsis, and death. Multiple peer-reviewed studies report significantly higher NEC rates in preemies fed cow's milk-based formula compared with human milk.
Lawsuits allege that Mead Johnson (Enfamil) and Abbott Laboratories (Similac) knew about this risk and failed to adequately warn hospitals and parents — placing profits over the safety of vulnerable premature infants. State court juries have already awarded over $625 million to plaintiffs, including a $70 million Cook County verdict in April 2026.
Who qualifies for an NEC baby formula lawsuit?
Typically: a premature or very low birth-weight infant who received Enfamil or Similac in the NICU and/or at home, with a confirmed NEC diagnosis and resulting surgery, long-term complications, or wrongful death.
Mixed feeding (both breast milk and formula) does not automatically disqualify a claim. Eligibility depends on timing, duration, and clinical course, evaluated by attorneys and medical experts.
What evidence should we gather for an NEC lawsuit?
The most valuable records are NICU notes, feeding and formula logs, medication records, operative reports, pathology results, imaging, discharge summaries, and pediatric follow-up notes. At-home feeding documentation is also helpful.
You do not need all records in hand before reaching out. Your attorney can help identify what is needed and assist in obtaining records from the hospital and NICU.
Do I sue the hospital, the manufacturer, or both?
Most NEC lawsuits focus on product manufacturers — Mead Johnson (Enfamil) and Abbott Laboratories (Similac) — under failure-to-warn and product liability theories. Whether the hospital may also be a defendant depends on your specific facts and state law. An attorney can evaluate all potential defendants based on your situation.
How much are NEC baby formula lawsuit settlements worth?
No global settlement has been reached in the federal MDL. State court juries have awarded over $625 million to date, including a $495 million verdict against Abbott (Missouri, July 2024), a $60 million verdict against Mead Johnson (Illinois, March 2024), and a $70 million verdict against Abbott (Cook County, April 2026 — Abbott appealing). Illustrative individual ranges: NEC with conservative care ($50,000–$250,000+); NEC with surgery ($250,000–$1M+); long-term disability ($500,000–$2M+); wrongful death ($1M–$5M+).
These ranges are educational only and not a guarantee of outcome. Actual results depend on medical severity, documentation, venue, jury trends, and case-specific facts.
What if my child received both breast milk and formula?
Mixed feeding does not automatically disqualify your claim. Eligibility depends on the timing and duration of formula use relative to the NEC diagnosis, reviewed by attorneys and medical experts on a case-by-case basis.
How long do I have to file an NEC lawsuit?
Deadlines vary by state and claim type, typically 1 to 3 years for product liability. Many states toll (pause) the deadline until the child turns 18, then add additional years. Wrongful death deadlines differ from personal injury deadlines.
Missing your deadline permanently bars your claim. Speak to an attorney immediately — do not assume it is too late without confirming your state's specific rules.
Is Mead Johnson's bellwether trial going forward?
Yes. On May 8, 2026, Judge Pallmeyer denied Mead Johnson's motion for summary judgment in Inman v. Mead Johnson, allowing the case to proceed to trial — the first time a defense summary judgment motion has been denied in this MDL. The trial is expected in August 2026 and will be the first federal bellwether to test the litigation's claims specifically against Mead Johnson before a jury, following Abbott's four consecutive summary judgment wins in earlier federal bellwethers.
Has there been an NEC class action settlement?
No global class action settlement has been finalized. A Cook County jury awarded $70 million against Abbott on April 9–10, 2026 — the second state court plaintiff verdict in Illinois — with Abbott stating it will appeal. Abbott has won summary judgment in four straight federal MDL bellwether trials, largely on expert testimony grounds. In a shift for the litigation, Mead Johnson's own summary judgment motion was denied in May 2026, sending a case to trial for the first time — expected in August 2026. The Missouri defense verdict — previously the only defense win — was overturned for misconduct and a retrial ordered. State court verdicts total over $625 million to date. Individual case values depend on specific facts and venue.
